Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Percheron Therapeutics Limited is a Biotechnology Research brand in Melbourne, Victoria. Ownership is publicly held; it publishes at percherontx.com. It holds one address on record, all in Australia. The record counts 9 people. One Australian registration (ABN) is a candidate match. It is listed alongside nine similar brands, mostly in Biotechnology Research.
ABN41095060745
| PERCHERON THERAPEUTICS LIMITED | ABN 41095060745 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Percheron Therapeutics Limited (ASX: PER) is an international biotechnology company focused on the development of novel therapies for rare diseases.
The company’s lead program is ATL1102, an antisense oligonucleotide targeting the CD49d receptor. ATL1102 is currently the subject of an ongoing international phase IIb clinical trial for the treatment of non-ambulant patients with Duchenne Muscular Dystrophy (DMD), for which data is expected in 2H CY2024. The drug has previously reported promising results from an exploratory phase IIa study in the same population and has been awarded orphan drug designation (ODD) and rare pediatric disease designation (RPDD) by the US FDA.
For more information, please contact info@PercheronTx.com.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
One Victoria entity on the ABR. PERCHERON THERAPEUTICS LIMITED (ABN 41 095 060 745), medium confidence.
The record holds 9 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Australia only. Primary: L30, 35 Collins Street, Melbourne, Victoria 3000.
None linked to this brand.
7 profiles list Percheron Therapeutics Limited as a peer — 73rd percentile in Biotechnology Research. It lists ten peers of its own. Currus Biologics Pty Ltd and Aculeus Therapeutics list it back.